The global Liver Medicine Market is experiencing steady growth, supported by the expanding need for medicines used in the management of liver-related conditions. The market size is expected to increase from US$ 29.8 billion in 2025 to US$ 53.33 billion by 2034. With an estimated compound annual growth rate (CAGR) of 6.68% from 2026 to 2034, the market reflects continued growth potential...